The most well-studied context of pathological caspase-9 activation is in neurodegenerative disease, where multiple studies have reported increased expression of both total and cl-caspase-9 in apoptotic neurons, glial cells, serum and CSF (Table 2). The gene discussed is CASP9; the disease is neurodegenerative disease.